-
Diagnostics World News Contributed Commentary | The benefits of proper infection control are well-known in the long-term care community. Newly-developed diagnostic and data sharing technologies have the potential to change how infections are understood and treated in long-term care.
Jan 28, 2020
-
Diagnostics World News | Researchers from Rush University Medical Center are taking a unique approach to cancer immunotherapy: a flu shot.
Jan 22, 2020
-
Diagnostics World News Brief | Qlucore is expanding into the area of precision medicine and precision diagnostics. In order to finance the expansion, Qlucore has recently finalized a rights issue of 400k Euros and is pleased to announce two new members of the Board.
Jan 21, 2020
-
Diagnostics World News | Bryan Wheelock, a principal in the St. Louis office of Harness, Dickey & Pierce, discusses how the current climate around diagnostic patentability is impacting the market and what to watch for next.
Jan 20, 2020
-
Diagnostics World News | At May’s Diagnostic Innovation Summit in Lisbon, Portugal, key opinion leaders will share the latest tools, clinical applications, and commercial product launches for liquid biopsies, infectious disease, and point-of-care testing. They will address regulatory changes, implementation challenges, and the path forward for diagnostic innovation.
Jan 17, 2020
-
Diagnostics World News | In 2012, Michael Snyder created an integrative personal omics profile, an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual. Today, Snyder is incorporating data from smart watches, continuous glucose monitoring, and other wearables to track people’s health and find early signs of disease.
Jan 16, 2020
-
Diagnostics World News | Despite the explosion of interest in the microbiome and the array of companies examining its composition, there remains an unmet clinical need for measuring microbiome function. And it’s a void Atmo Biosciences is looking to fill.
Jan 14, 2020
-
Diagnostics World News Contributed Commentary | The need for more accurate diagnostics for acute infections is clear, and several novel and promising diagnostic technologies have come to market recently, with more in the pipeline.
Jan 10, 2020
-
Diagnostics World News | As we head into 2020, we at Diagnostics World News would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.
Jan 9, 2020
-
Diagnostics World News | Caris announced the launch of its MI GPS (Genomic Profiling Similarity) Score, an AI-driven tumor type biology similarity score that uses a machine learning algorithm to compare molecular characteristics of a patient’s tumor against Caris’ database.
Jan 8, 2020
-
Diagnostics World News | Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology. Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies, and more.
Jan 7, 2020
-
Diagnostics World News | Last month NANOPEC Technologies announced MetaFluorex, a new class of proprietary nano-structured ceramic films, that the company says have shown to enhance fluorescent signals by factors as large as 100 times, depending on the assay, when compared to the glass slides currently used for in vitro diagnostic testing.
Jan 3, 2020
-
Diagnostics World News | A Duke University spin-out company is putting the last touches on a host response bacterial-viral test entering the final leg of the Antimicrobial Resistance (AMR) Diagnostic Challenge of the National Institutes of Health Division of Program Coordination, Planning, and Strategic Initiatives.
Jan 2, 2020
-
Diagnostics World News | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Charles River, Takeda, Veracyte, and more.
Dec 23, 2019
-
Diagnostics World News | Researchers have known for a very long time that proteins circulating in human blood can, like the proverbial canary in the coal mine, be signals of health and disease risk. Until recently, the association has been exploited only in one-at-a-time experiments, usually with mass spectrometry technology.
Dec 19, 2019
-
Diagnostics World News | Ativa’s diagnostic workstation claims to be the only point-of-care system using a big-data approach to blood and urine testing to provide results on the major test panels used today to diagnose patients, and advanced diagnostic tests that gives deeper, more concise, disease information. If that sounds to you too good to be true, Ativa’s co-founder and CEO, is quick to point the company’s secrets to success: a team approach with solid partnerships, AI-driven analysis, and a seismic shift in the way data is collected for diagnostic testing.
Dec 18, 2019
-
Diagnostics World News | The Foundation for the National Institutes of Health is laser-focused on potentially transformative drug development tools that require group devotion to “not-so-sexy” science.
Dec 17, 2019
-
Diagnostics World News Brief | Ontera and QuantuMDx announced a collaboration this week to create a next-generation solution for blood stream infection and drug resistance detection. The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s powerful nanopore biosensor, currently used in their SAM and DUO Nano platforms.
Dec 12, 2019
-
Diagnostics World News Brief | Charles River announced that it has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers consistent and efficient reprogramming of human cells for use in research, drug discovery, and cell therapies.
Dec 11, 2019
-
Diagnostics World News | Most patients, as well as most primary care physicians, consider lung cancer to be highly lethal. That’s because early-stage disease tends to be discovered by accident rather than intentionally through screening, leading Lahey Hospital & Medical Center to develop a high-volume CT lung cancer screening program, which is scanning about 65% of the eligible population with impressive results.
Dec 9, 2019